Impairments in executive functioning in patients with remitted and non-remitted schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 4, 2011, Pages 1148-1154

  Yun, Da Young ^a   Hwang, Samuel Suk Hyun ^b   Kim, Yeni ^c   Lee, Young Ho ^d   Kim, Yong Sik ^a   Jung, Hee Yeon ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University Hospital   (South Korea)

^d The Catholic University of Korea   (South Korea)

Author keywords

CANTAB; Executive function; Remission; Schizophrenia; Symptom

Indexed keywords

ACUTE DISEASE; ADULT; ANALYTICAL ERROR; ANXIETY DISORDER; ARTICLE; BECK ANXIETY INVENTORY; CAMBRIDGE NEUROPSYCHOLOGICAL AUTOMATED TEST BATTERY; CHOICE REACTION TIME TEST; CLINICAL ASSESSMENT TOOL; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ACTIVITY; EXECUTIVE FUNCTION; FEMALE; HUMAN; KOREAN WECHSLER ADULT INTELLIGENCE SCALE; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; NON REMITTED SCHIZOPHRENIA; RATING SCALE; REMITTED SCHIZOPHRENIA; RESPONSE TIME; SCHIZOPHRENIA; SCORING SYSTEM; STOP SIGNAL TEST;

ACUTE DISEASE; ADULT; ANXIETY; DATA INTERPRETATION, STATISTICAL; EXECUTIVE FUNCTION; FEMALE; HUMANS; INTELLIGENCE; MALE; MEMORY, SHORT-TERM; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SCHIZOPHRENIC PSYCHOLOGY; WECHSLER SCALES;

EID: 79956056271     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.03.018     Document Type: Article

References (66)

1. Andreasen N.C., Carpenter W.T., Kane J.M., Lasser R.A., Marder S.R., Weinberger D.R. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005, 162:441-449.
2. Andres P. Frontal cortex as the central executive of working memory: time to revise our view. Cortex 2003, 39:62-68.
3. Baddeley A.D. Working memory 1986, Oxford University Press, Oxford.
4. Baddeley A.D., Della Sala S. Working memory and executive control. The prefrontal cortex: executive and cognitive functions 1998, 9-21. Oxford University Press, Oxford. A.C. Roberts, T.W. Robbins, L. Weiskrantz (Eds.).
5. Barkely R.A. Behavioral inhibition, sustained attention, and executive function: constructing a unifying theory of ADHD. Psychol Bull 1997, 121:65-94.
6. Baxter R.D., Liddle P.F. Neuropsychological deficits associated with schizophrenic syndromes. Schizophr Res 1998, 30:239-249.
7. Beck A.T., Epstein N., Brown G., Steer R.A. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988, 56:893-897.
8. Bell M.D., Lysaker P.H., Milstein R.M., Beam-Goulet J.L. Concurrent validity of the cognitive component of schizophrenia: relationship of PANSS scores to neuropsychological assessments. Psychiatry Res 1994, 54:51-58.
9. Bishop S., Duncan J., Brett M., Lawrence A.D. Prefrontal cortical function and anxiety: controlling attention to threat-related stimuli. Nat Neurosci 2004, 7:184-188.
10. Bishop S. Trait anxiety and impoverished prefrontal control of attention. Nat Neurosci 2008, 12:92-98.
11. Braga R.J., Petrides G., Figueira I. Anxiety disorders in schizophrenia. Compr Psychiatry 2004, 45:460-468.
12. Brown K.W., White T. Syndromes of chronic schizophrenia and some clinical correlates. Br J Psychiatry 1992, 161:317-322.
13. Burgess P.W., Shallice T. Response suppression, initiation and strategy use following frontal lobe lesions. Neuropsychologia 1996(a), 34:263-273.
14. Burgess P.W., Shallice T. Bizarre responses, rule detection, and frontal lobe lesions. Cortex 1996(b), 32:1-19.
15. CANTABeclipse CANTABeclipse administration manual 2006, Cognition Limited, Cambridge.
16. Chan R.C.K., Chen E.Y.H., Law C.W. Specific executive dysfunction in patients with first-episode medication-naive schizophrenia. Schizophr Res 2006, 82:51-64.
17. Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington DC. 4th ed.
18. Dibben C.R.M., Rice C., Laws K., Mckenna P.J. Is executive impairment associated with schizophrenic syndromes? A meta-analysis. Psychol Med 2009, 39:381-392.
19. Enticott P.G., Ogloff J.R.P., Bradshaw J.L. Response inhibition and impulsivity in schizophrenia. Psychiatry Res 2008, 157:251-254.
20. Fray P.J., Robbins T.W., Sahakian B.J. Neuropsychiatric applications of CANTAB. Int J Geriatr Psychiatry 1996, 11:329-336.
21. Goethals I., Audenaert K., Van de W.C., Dierckx R. The prefrontal cortex: insights from functional neuroimaging using cognitive activation tasks. Eur J Nucl Med Mol Imaging 2004, 31:408-416.
22. González-Blanch C., Crespo-Facorro B., Alvarez-Jiménez M., Rodríguez-Sánchez J.M., Pérez-Iglesias R., Pelayo-Terán J.M., et al. Lack of association between clinical and cognitive change in first-episode psychosis: the first 6weeks of treatment. Can J Psychiatry 2008, 53:839-847.
23. Green M.F., Nuechterlein K.H. Should schizophrenia be treated as a neurocognitive disorder?. Psychiatry Res 1999, 25:309-319.
24. Helldin L., Kane J.M., Karilampi U., Norlander T., Archer T. Remission and cognitive ability in a cohort of patients with schizophrenia. J Psychiatr Res 2006, 40:739-745.
25. Inada T. Evaluation and diagnosis of drug-induced extrapyramidal symptoms: commentary on the DIEPSS and guide to its usage 1996, Seiwa Shoten Publishers, Tokyo.
26. Joyce E., Hutton S., Mutsatsa S., Gibbins H., Webb E., Paul S., et al. Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis: the West London Study. Br J Psychiatry 2002, 181(suppl. 43):38-44.
27. Kay S.R., Opler L.A. The positive-negative dimension in schizophrenia: its validity and significance. Psychiatr Dev 1987, 2:79-103.
28. Keefe R.S.E., Fenton W.S. How should DSM-V criteria for schizophrenia include cognitive impairment?. Schizophr Bull 2007, 33:912-920.
29. Keefe R.S.E., Sweeney J.A., Gu H., Hamer R.M., Perkins D.O., McEvoy J.P., et al. Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison. Am J Psychiatry 2007, 164:1061-1071.
30. Kim J.H., Jung H.Y., Kang U.G., Jeong S.H., Ahn Y.M., Byum H.J., et al. Metric characteristics of the Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS): a practical combined rating scale for drug-induced movement disorders. Mov Disord 2002, 17:1354-1359.
31. Kim J.S., Lee Y.S. Validity of short forms of the Korean-Wechsler Adult Intelligence Scale. Korean J Clin Psychology 1995, 14:111-116.
32. Kopelowicz A., Liberman R.P., Ventura J., Zarate R., Mintz J. Neurocognitive correlates of recovery from schizophrenia. Psychol Med 2005, 35:1165-1173.
33. Krishnadas R., Moore B.P., Nayak A., Patel R.R. Relationship of cognitive function in patients with schizophrenia in remission to disability: a cross-sectional study in an Indian sample. Ann Gen Psychiatry 2007, 6:1-8.
34. Kroken R.A., Johnsen E., Ruud T., Wentzel-Larsen T., Jørgensen H.A. Treatment of schizophrenia with antipsychotics in Norwegian emergency wards, a cross-sectional national study. BMC Psychiatry 2009, 9:24.
35. Kwon SM. Psychometric characteristics of the Korean version of the Beck Anxiety Inventory. Unpublished data. 1997.
36. Lawrence A.D., Grasby P.M. The functional neuroanatomy of emotional disorders. In Handbook of Neuropsychology 2nd edition 2001, 5:235-262. Elsevier, Amsterdam. G. Gainotti (Ed.).
37. Laws K.R. A meta-analytic review of Wisconsin Card Sort studies in schizophrenia: a general intellectual deficit in disguise?. Cognitive Neuropsych 1999, 4:1-35.
38. Lezak M.D. Neuropsychological assessment 1995, Oxford University Press, New York. 4th ed.
39. Liddle P.F. Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychol Med 1987, 17:49-57.
40. Liddle P.F., Morris D.L. Schizophrenic syndromes and frontal lobe performance. Br J Psychiatry 1991, 158:340-345.
41. Lysaker P.H., Whitney K. Clinical and psychosocial correlates of anxiety-related symptoms in schizophrenia. Progress in anxiety disorder research 2005, Nova Science Publishers, Inc., Hauppauge, NY. C.M. Velotis (Ed.).
42. McGurk S.R., Meltzer H.Y. The role of cognition in vocational functioning in schizophrenia. Schizophr Res 2000, 45:175-184.
43. Milner B. Effects of different brain lesions on card sorting. Arch Neurol 1963, 9:307-316.
44. Miyake A., Friedman N.P., Emerson M.J., Witzki A.H., Howerter A., Wager T.D. The unity and diversity of executive functions and their contributions to complex "frontal lobe" tasks: a latent variable analysis. Cogn Psychol 2000, 41:49-100.
45. Mohamed S., Paulsen J.S., O'Leary D., Arndt S., Andreasen N.C. Generalized cognitive deficits in schizophrenia: a study of first episode patients. Arch Gen Psychiatry 1999, 56:749-754.
46. Norman D.A., Shallice T. Attention to action: willed and automatic control of behavior. Consciousness and self-regulation: advances in research and theory 1986, 4:1-18. Plenum, New York.
47. Pallanti S., Quercioli L., Hollander E. Social anxiety in outpatients with schizophrenia: a relevant cause of disability. Am J Psychiatry 2004, 161:53-58.
48. Pantelis C., Barnes T.R.E., Nelson H.E., Tanner S., Weatherley L., Owen A.M., et al. Frontal-striatal cognitive deficits in patients with chronic schizophrenia. Brain 1997, 120:1823-1843.
49. Pennington B.F., Ozonoff S. Executive functions and developmental psychopathology. J Child Psychol Psychiatry 1996, 37:51-87.
50. Pradhan B.K., Chakrabarti S., Nehra R., Mankotia A. Cognitive functions in bipolar affective disorder and schizophrenia: comparison. Psychiatry Clin Neurosci 2008, 62:515-525.
51. Rund B.R., Melle I., Friis S., Larsen T.K., Midboe L.J., Opjordsmoen S., et al. Neurocognitive dysfunction in first-episode psychoses: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis. Am J Psychiatry 2004, 161:466-472.
52. Rund B.R., Sundet K., Asbjorsen A., Egeland J., Landro N.I., Lund A., et al. Neuropsychological test profiles in schizophrenia and non-psychotic depression. Acta Psychiatr Scand 2006, 113:350-359.
53. Rushe T.M., Morris R.G., Miotto E.C., Feigenbaum J.D., Woodruff P.W.R., Murray R.M. Problem-solving and spatial working memory in patients with schizophrenia and with focal frontal and temporal lobe lesions. Schizophr Res 1999, 37:21-33.
54. Shin L.M., Whalen P.J., Pitman R.K., Bush G., Macklin M.L., Lasko N.B., et al. An fMRI study of anterior cingulate function in posttraumatic stress disorder. Biol Psychiatry 2001, 50:932-942.
55. Smitherman T.A., Huerkamp J.K., Miller B.I., Houle T.T., O'Jile J.R. The relation of depression and anxiety to measures of executive functioning in a mixed psychiatric sample. Arch Clin Neuropsychol 2007, 22:647-654.
56. SPSS, Inc: SPSS for Windows. Chicago, IL, USA: Rel 13.0; 2004.
57. Stins J.F., Tollenaar M.S., Slaats-Willemse D.I.E., Buitelaar J.K., Swaab-Barneveld H., Verhulst F.C., et al. Sustained attention and executive functioning performance in attention-deficit/hyperactivity disorder. Child Neuropsychol 2005, 11:285-294.
58. Stratta P., Prosperini P., Daneluzzo E., Bustini M., Rossi A. Educational level and age influence spatial working memory and Wisconsin Card Sorting Test performance differently: a controlled study in schizophrenic patients. Psychiatry Res 2001, 102:39-48.
59. Stuss D.T., Shallice T., Alexander M.P., Picton T.W. A multidisciplinary approach to anterior attentional functions. Ann NY Acad Sci 1995, 769:191-211.
60. Szoke A., Trandafir A. Longitudinal studies of cognition in schizophrenia: meta-analysis. Br J Psychiatry 2008, 192:248-257.
61. Thoma P., Wiebel B., Daum I. Response inhibition and cognitive flexibility in schizophrenia with and without co-morbid substance use disorder. Schizophr Res 2007, 92:168-180.
62. Velligan D.I., Bow-Thomas C.C. Executive function in schizophrenia. Semin Clin Neuropsychiatry 1999, 4:24-33.
63. Wechsler D. Wechsler Adult Intelligence Scale-Revised Manual 1981, The Psychological Corporation, New York.
64. Yeom T.H., Park Y.S., Oh K.J., Kim J.K., Lee Y.H. Korean Wechsler Adult Intelligence Scale (K-WAIS) Manual 1992, Hankook Guidance, Seoul.
65. Yi J.S., Ahn Y.M., Shin H.K., An S.K., Joo Y.H., Kim S.H., et al. Reliability and validity of the Korean version of the Positive and Negative Syndrome Scale. J Korean Neuropsychiatric Association 2001, 40:1090-1105.
66. Yoruganti L.N.P., Heslegrave R.J., Awad A.G. Neurocognitive correlates of positive and negative syndromes in schizophrenia. Can J Psychiatry 1997, 42:1066-1071.